The 20Med NP platform is broadly applicable for the intracellular delivery of nucleotide-based payloads.
Our focus is on the development of RNA and DNA based vaccines and therapeutics. Our platform is being applied in several human and animal indications to help accelerate partnered programs towards clinical trials.
Compatible with all types of nucleotide-based payloads such as oligonucleotides and mRNA or DNA
Different routes of administration: intramuscular, intradermal, subcutaneous, intra-tumoral and intra-articular
Wide range of applications